google-site-verification: googlec7193c3de77668c9.html
Thursday , September 10 2026

Developing a human hepatocyte model with enhanced drug-metabolizing enzyme activity

[
A research team led by Associate Professor Shinpei Yamaguchi and the late Professor Masako Tada of the Faculty of Science, together with Professor Yojiro Anzai and Lecturer Yohei Iizaka of the Faculty of Pharmaceutical Sciences at Toho University, have developed a new HepaRG cell line with markedly enhanced activity of CYP2D6, a major drug-metabolizing enzyme. This engineered human hepatocyte model enables more human-relevant evaluation of drug-induced hepatotoxicity mediated by CYP2D6. The study was published in the journal PLOS ONE on December 29, 2025.


Source link

Advertisements

See also  'Sunburn tattoo' trend sparks serious dermatologists' warnings

Check Also

Economic tool could help cities prioritize public health in urban development

[ Credit: Treasured Solitude from Pexels Senior urban development decision-makers have revealed there is currently …

UK needs new laws for AI in healthcare, says watchdog

The UK needs new regulations for AI products used in the NHS and other healthcare …

Odds of imaging order higher when clinicians self-interpret

[ Providers who self-interpret imaging are significantly more likely to order outpatient imaging, according to …

Leave a Reply

Available for Amazon Prime